Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.37 USD | -5.74% | -16.38% | +2.95% |
Jun. 01 | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
May. 13 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.95% | 2.34B | |
-39.42% | 8.27B | |
+1.33% | 3.35B | |
-19.81% | 2.02B | |
-23.12% | 1.62B | |
+33.59% | 1.16B | |
-7.21% | 713M | |
+11.33% | 696M | |
-32.45% | 488M | |
-6.86% | 274M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Piper Sandler Adjusts Iovance Biotherapeutics Price Target to $19 From $18, Maintains Overweight Rating